Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2002 Mar 1;79(1):136–146. doi: 10.1093/jurban/79.1.136

Trends in the AIDS epidemic among New York City’s injection drug users: Localized or citywide?

Russell Rockwell 1,✉, Sherry Deren 1, Marjorie F Goldstein 1, Samuel R Friedman 1, Don C Des Jarlais 1,✉
PMCID: PMC3456374  PMID: 11937622

Abstract

The New York City injection drug user acquired immunodeficiency syndrome (IDU AIDS)epidemic accounts for almost one quarter of AIDS cases in IDUs in the United States. Recent studies have reported declines in seroprevalence and risk behaviors among IDUs in New York City during the 1990s. These trends, however, are based on studies primarily conducted in the city’s central borough of Manhattan. This article analyzes data from all five boroughs of New York City to examine trends over phases of the epidemic and to determine the level of prevention services available; an exploratory qualitative study was also conducted to assess access to prevention services and injection practices in areas in the “outer boroughs”. Findings indicated that (1)borough differences in services and behaviors existed from early in the epidemic; (2)services have been concentrated in Manhattan; and (3)declines in seroprevalence were greatest among Manhattan-recruited IDUs. Enhancing access to services for IDUs in the boroughs outside Manhattan may be needed to continue the positive trends in all areas of New York City.

Keywords: Human Immunodeficiency Virus, York City, Human Immunodeficiency Virus Infection, Inject Drug User, York City Department

Full Text

The Full Text of this article is available as a PDF (86.2 KB).

References

  • 1.Des Jarlais DC, Perlis TE, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City 1991–1996. Am J Public Health. 1998;88(12):1801–1806. doi: 10.2105/AJPH.88.12.1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86(5):642–654. doi: 10.2105/AJPH.86.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.New York City Department of Health . AIDS Surveillance Update. New York, NY: New York City Department of Health; 1999. [Google Scholar]
  • 4.Des Jarlais DC, Friedman SR, Novick DM, Sotheran JL, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261(7):1008–1012. doi: 10.1001/jama.1989.03420070058030. [DOI] [PubMed] [Google Scholar]
  • 5.Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an epidemic: injecting drug users in New York City, 1984 through 1992. JAMA. 1994;271(2):121–127. doi: 10.1001/jama.1994.03510260053028. [DOI] [PubMed] [Google Scholar]
  • 6.Friedman SR, Chapman TF, Perlis TE, et al. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991–1996. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;22(1):83–91. doi: 10.1097/00042560-199909010-00011. [DOI] [PubMed] [Google Scholar]
  • 7.Beardsley M, Deren S, Tortu S, Goldstein MF, Ziek K, Hamid R. Trends in injection risk behaviors in a sample of New York City injection drug users: 1992–1995. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20(3):283–289. doi: 10.1097/00042560-199903010-00011. [DOI] [PubMed] [Google Scholar]
  • 8.Des Jarlais DC, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. Am J Public Health. 2000;90(3):352–359. doi: 10.2105/AJPH.90.3.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Des Jarlais DC, Perlis TE, Fridman SR, et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990–1997. Am J Public Health. 2000;90(7):1112–1116. doi: 10.2105/AJPH.90.7.1112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–991. doi: 10.1016/S0140-6736(96)02536-6. [DOI] [PubMed] [Google Scholar]
  • 11.Des Jarlais DC, Friedman SR, Perlis TE, et al. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20(1):67–72. doi: 10.1097/00042560-199901010-00010. [DOI] [PubMed] [Google Scholar]
  • 12.Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321(13):874–879. doi: 10.1056/NEJM198909283211306. [DOI] [PubMed] [Google Scholar]
  • 13.Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep. 1998;113(suppl 1):107–115. [PMC free article] [PubMed] [Google Scholar]
  • 14.Friedman SR, Des Jarlais DC, Sotheran JL, Garber J, Cohen H, Smith D. AIDS and self-organization among intravenous drug users. Int J Addict. 1987;22:201–209. doi: 10.3109/10826088709027425. [DOI] [PubMed] [Google Scholar]
  • 15.Des Jarlais DC, Friedman SR, Hopkins W. Risk reduction for the acquired immune deficiency syndrome among intravenous drug users. Ann Intern Med. 1985;103(5):755–759. doi: 10.7326/0003-4819-103-5-755. [DOI] [PubMed] [Google Scholar]
  • 16.Gostin LO, Ward JW, Baker AC. National HIV case reporting in the United States: a defining moment in the history of the epidemic. N Engl J Med. 1997;337:1162–1167. doi: 10.1056/NEJM199710163371611. [DOI] [PubMed] [Google Scholar]
  • 17.Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users. AIDS. 1996;10(14):1729–1734. doi: 10.1097/00002030-199612000-00018. [DOI] [PubMed] [Google Scholar]
  • 18.Rockwell R, Des Jarlais DC, Friedman SR, Perlis TE, Paone D. Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care. 1999;11(4):437–442. doi: 10.1080/09540129947811. [DOI] [PubMed] [Google Scholar]
  • 19.Hutchinson SJ, Taylor A, Goldberg D, Gruer L. Factors associated with injecting risk behavior among serial community-wide samples of injecting drug users in Glasgow 1990–1994: implications for control and prevention of blood-borne viruses. Addiction. 2000;95(6):931–940. doi: 10.1046/j.1360-0443.2000.9569319.x. [DOI] [PubMed] [Google Scholar]
  • 20.National Institutes of Health . NIH Consensus Statement. Bethesda, MD: National Institutes of Health; 1997. Interventions to prevent HIV risk behaviors; pp. 1–41. [PubMed] [Google Scholar]
  • 21.Dasgupta S, Friedman SR, Jose B. Using retrospective behavioral data to determine HIV risk factors among street-recruited drug injectors. J Drug Issues. 1995;25(1):161–171. doi: 10.1177/002204269502500111. [DOI] [Google Scholar]
  • 22.Friedman SR, Des Jarlais DC, Goldsmith DS. An overview of AIDS prevention efforts aimed at intravenous drug users circa 1987. J Drug Issues. 1989;19(1):93–109. doi: 10.1177/002204268901900107. [DOI] [Google Scholar]
  • 23.New York City Department of Health . HIV Seroprevalence Update. New York: New York City Department of Health; 1997. [Google Scholar]
  • 24.New York City Department of Health/AIDS Institute . New York State Authorized Syringe Exchange Programs Site Locations and Hours of Operation. New York, NY: New York City Department of Health; 2000. [Google Scholar]
  • 25.National Institute of Drug Abuse. Heroin abuse and addiction . Research Report Series. Bethesda, MD: National Institutes of Health; 1997. pp. 1–8. [Google Scholar]
  • 26.New York State Department of Health Proposed ruling: rules and regulations on controlled substances. New York State Register. 2000;22(50):13–16. [Google Scholar]
  • 27.Salsitz EA, Hoseph H, Frank B, et al. Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice—a summary report (1983–1998) Mt Sinai J Med. 2000;67(5/6):388–397. [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES